September 30, 2014 | By DEEPTI RAMESH
Consort Medical to acquire Aesica for $372 million Private equity firm Silverfleet Capital (London) says that it has agreed to sell its portfolio company Aesica Pharmaceuticals (Newcastle-upon-Tyne, UK) to health care firm Consort Medical (Hemel Hempstead, UK), for £230 million ($372 million). Aesica provides contract development and manufacturing services for active pharmaceutical ingredients (APIs)...
September 26, 2014 | By LINDSAY FROST
This Week in CW: BASF said on Wednesday that it is changing the organizational structure of its paper chemicals business to strengthen competiveness. As of 1 January 2015, the paper chemicals division will be dissolved and the current headquarters of the division in Basel will be closed by end 2014. The company will cut about 50 jobs globally as part of the restructuring. BASF, a leading global supplier to...
September 23, 2014 | By DEEPTI RAMESH
Merck KGaA to acquire Sigma-Aldrich for $17 billion Merck KGaA (Darmstadt, Germany) says it has entered into a definitive agreement to acquire Sigma-Aldrich (St. Louis) for $17 billion. Merck will acquire all of the outstanding shares of Sigma-Aldrich for $140/share in cash. The agreed price represents a 37% premium to the latest closing price of $102.37 on 19 September and a 36% premium to the one-month...
September 16, 2014 | By DEEPTI RAMESH
Seattle Genetics and Genmab enter into antibody-drug conjugate collaboration Biotechnology companies Seattle Genetics (Bothell, WA) and Genmab (Copenhagen) say that they have entered into an additional antibody-drug conjugate (ADC) collaboration. Genmab, under the new agreement, will pay an upfront fee of $11 million for exclusive rights to utilize Seattle Genetics’ auristatin-based ADC technology...
September 9, 2014 | By DEEPTI RAMESH
Mercachem to acquire Synthon’s API operations at Prague Mercachem (Nijmegen, Netherlands) says that it has agreed to acquire pharmaceutical company Synthon’s (Nijmegen) Prague-based laboratory and pilot scale operations for the manufacturing of active pharmaceutical ingredients (API). Financial details of the acquisition were not disclosed. Mercachem is a privately owned contract research...
September 5, 2014 | By LINDSAY FROST
This Week in CW: Pembina (Calgary, AB) has chosen Portland, OR, as the site for a $500-million, 30,000-bbl/day propane export facility. The company has also agreed to acquire the Vantage pipeline system and Mistral Midstream’s share of the Saskatchewan Ethane Extraction Plant (SEEP) for a total of $650 million Pembina expects to bring the so-called West Coast Terminal online in early 2018. Pembina...
September 2, 2014 | By DEEPTI RAMESH
Amerigen Pharmaceuticals, Ningbo Menovo sign generics deal; Menovo to manufacture APIs Amerigen Pharmaceuticals (Lyndhurst, NJ) and Ningbo Menovo Pharmaceutical (Ningbo, China) have entered into a collaboration agreement for the development of generic pharmaceuticals, primarily targeting the US market. Amerigen and Menovo, under the terms of the agreement, will jointly develop products for Amerigen to...
August 29, 2014 | By LINDSAY FROST
This Week in CW: Albemarle’s $6.2-billion acquisition of Rockwood Holdings was the result of an off-and-on 24-month courtship, according to a joint registration statement filed on Thursday by Albemarle and Rockwood. Discussions accelerated quickly in May and June as Rockwood M&A adviser Lazard pressed for bids and former Rockwood chairman and CEO Seifi Ghasemi prepared to retire from Rockwood to...
August 26, 2014 | By DEEPTI RAMESH
Siegfried reports a slight increase in profits Siegfried (Zofingen, Switzerland) reports a 1.6% rise in net profits for the first six months of 2014 compared with the year-ago period, to 18.8 million Swiss francs ($20.5 million). First-half sales decreased 16%, however, to SF165.1 million. Fluctuations in currency exchange rates and raw material prices as well as the introduction of a new technology during...
August 22, 2014 | By LINDSAY FROST
This Week in CW: Coatings maker Axalta has filed with the US Securities and Exchange Commission (SEC; Washington) for an initial public offering (IPO) of an undetermined value, according to regulatory filings. The filing, which consists of a preliminary prospectus, did not specify the timing of a potential IPO, or the price or number of shares in the offering. Axalta says it will use and any proceeds from...
ABOUT CHEM IDEAS
Welcome to Chem Ideas, the place for opinions and perspective on the key issues affecting the global chemicals industry. This zone features articles by Chemweek’s regular editors as well as a team of established experts with insights across the chemicals industry. If you would like to contribute a blog or opinion piece contact Lindsay.Frost@ihs.com.
CLICK HERE TO LEARN ABOUT CHEMWEEK'S EDITORS
ABOUT OUR GUEST AUTHORS
Fine Chemicals / Pharma
Girish Malhotra is the president and founder of Epcot International, an international consulting firm covering chemical manufacture. Girish is an established industry figure having held senior positions at companies including ExxonMobil and Sherwin Williams. He can be reached at firstname.lastname@example.org
Lawrence D. Sloan became Socma's
President in early 2010. He says he will continue to drive up the interests of his members on issues including regulation and best business practice.
Lisa Allen is the Technical Manager of ReachReady, the Reach services body affiliated to the Chemical Industries Assocation (CIA; U.K.).
She spends much of her time addressing concerns raised by ReachReady’s customers about Reach.
Kathryn Sheridan is the founder of Sustainability Consult, providing public relations support with a sustainability focus to a number of chemical industry clients, as well as to other sectors. Sustainability Consult helps organisations develop, promote and communicate their sustainability strategies, plans and activities. email@example.com
Rubber and Plastics
Lou Reade is a freelance journalist and expert in the rubber and plastics fields. Based in the U.K. Lou has more than a decade writing in about rubber and plastics manufacture with a wealth of experience gained while writing for the leading publications in the field in the U.K. and wider afield. Loureade@talk21.com.
Giles Chappell is an attorney based in Geneva. His practice focuses on chemicals—specifically REACH and the CLP Regulation, product safety legislation, environmental and trade compliance, and market access issues. He was recommended in 2012 by the Chambers & Partners legal directory. firstname.lastname@example.org
Steve Roberts is an attorney who practices in the rapidly developing area of homeland security law and regulation. Steve writes and speaks frequently on the legal aspects of homeland security and counterterrorism affecting the nation’s critical infrastructure. www.chemicalsecurity.com